NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









FYR Diagnostics

FYR Diagnostics

Private
Missoula, MontanaHealthcare & Life Scienceshttps://fyr.bio/

Last Round

Grant

Nov 19, 2025

Total Funding Raised

$3.57M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

FYR Diagnostics is a biotechnology company that develops biomarker detection technology and AI-enabled multi-omic insights to advance precision medicine and diagnostic solutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

extracellular vesiclesEVbiomarker discoverymolecular diagnosticsliquid biopsymultiomicsdiagnostic platformAI-enabled diagnosticsprecision medicineclinical trial supportbiotech R&Dassay developmentmachine learning pipelinesbiotech services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FYR Diagnostics Comps

Public and private peers based on sector, stage, and business model.

FYR Diagnostics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

FYR Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 19, 2025
VC RoundSep 24, 2025
GrantAug 15, 2021
GrantDec 1, 2020
GrantOct 10, 2019

Key People

Founding team and executive leadership

Chris Booth

Chief Executive Officer

Executive Team

Barbara K. Zehentner

Chief Operating Officer

Executive Team

FYR Diagnostics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 10, 2026

    Barbara K. Zehentner appointed as new COO.

  • Sep 24, 2025

    $8M raised in early funding.

FYR Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

FYR Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about FYR Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMissoula, Montana
Employee Range21
Year Founded2016
Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.